These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 33918207)

  • 1. Curcumin and Its Modified Formulations on Inflammatory Bowel Disease (IBD): The Story So Far and Future Outlook.
    Karthikeyan A; Young KN; Moniruzzaman M; Beyene AM; Do K; Kalaiselvi S; Min T
    Pharmaceutics; 2021 Apr; 13(4):. PubMed ID: 33918207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A review on curcumin colon-targeted oral drug delivery systems for the treatment of inflammatory bowel disease.
    Sardou HS; Vosough PR; Abbaspour M; Akhgari A; Sathyapalan T; Sahebkar A
    Inflammopharmacology; 2023 Jun; 31(3):1095-1105. PubMed ID: 36757584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Curcumin has bright prospects for the treatment of inflammatory bowel disease.
    Hanai H; Sugimoto K
    Curr Pharm Des; 2009; 15(18):2087-94. PubMed ID: 19519446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Curcumin, an active component of turmeric in the prevention and treatment of ulcerative colitis: preclinical and clinical observations.
    Baliga MS; Joseph N; Venkataranganna MV; Saxena A; Ponemone V; Fayad R
    Food Funct; 2012 Nov; 3(11):1109-17. PubMed ID: 22833299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the Use of Curcumin on Ulcerative Colitis and Crohn's Disease: A Systematic Review.
    Goulart RA; Barbalho SM; Lima VM; Souza GA; Matias JN; Araújo AC; Rubira CJ; Buchaim RL; Buchaim DV; Carvalho ACA; Guiguer ÉL
    J Med Food; 2021 Jul; 24(7):675-685. PubMed ID: 33155879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of curcumin and its nanopreparations in the treatment of inflammatory bowel disease.
    Meng ZW; Chang B; Sang LX
    World J Gastroenterol; 2024 Jan; 30(3):280-282. PubMed ID: 38314128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review of the Effects and Mechanism of Curcumin in the Treatment of Inflammatory Bowel Disease.
    Lin Y; Liu H; Bu L; Chen C; Ye X
    Front Pharmacol; 2022; 13():908077. PubMed ID: 35795556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.
    Pedersen G
    Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
    Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
    Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is Curcumin a Possibility to Treat Inflammatory Bowel Diseases?
    Mazieiro R; Frizon RR; Barbalho SM; Goulart RA
    J Med Food; 2018 Nov; 21(11):1077-1085. PubMed ID: 29957091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Curcuminoids from
    Cunha Neto F; Marton LT; de Marqui SV; Lima TA; Barbalho SM
    Crit Rev Food Sci Nutr; 2019; 59(13):2136-2143. PubMed ID: 29565637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Impact of Inflammatory Bowel Disease in Canada 2018: Direct Costs and Health Services Utilization.
    Kuenzig ME; Benchimol EI; Lee L; Targownik LE; Singh H; Kaplan GG; Bernstein CN; Bitton A; Nguyen GC; Lee K; Cooke-Lauder J; Murthy SK
    J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S17-S33. PubMed ID: 31294382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curcumin as a therapeutic agent for blocking NF-κB activation in ulcerative colitis.
    Wang Y; Tang Q; Duan P; Yang L
    Immunopharmacol Immunotoxicol; 2018 Dec; 40(6):476-482. PubMed ID: 30111198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Curcumin and inflammatory bowel disease: potential and limits of innovative treatments.
    Vecchi Brumatti L; Marcuzzi A; Tricarico PM; Zanin V; Girardelli M; Bianco AM
    Molecules; 2014 Dec; 19(12):21127-53. PubMed ID: 25521115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plant-Derived Exosomes as a Drug-Delivery Approach for the Treatment of Inflammatory Bowel Disease and Colitis-Associated Cancer.
    Cai Y; Zhang L; Zhang Y; Lu R
    Pharmaceutics; 2022 Apr; 14(4):. PubMed ID: 35456656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic roles of curcumin: lessons learned from clinical trials.
    Gupta SC; Patchva S; Aggarwal BB
    AAPS J; 2013 Jan; 15(1):195-218. PubMed ID: 23143785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation, characterization and anti-colitis activity of curcumin-asafoetida complex encapsulated in turmeric nanofiber.
    Gopi S; Amalraj A; Jude S; Varma K; Sreeraj TR; Haponiuk JT; Thomas S
    Mater Sci Eng C Mater Biol Appl; 2017 Dec; 81():20-31. PubMed ID: 28887965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of Plant-Derived Natural Products in the Management of Inflammatory Bowel Disease-What Is the Clinical Evidence So Far?
    Davila MM; Papada E
    Life (Basel); 2023 Aug; 13(8):. PubMed ID: 37629560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Target-Based Small Molecule Drug Discovery Towards Novel Therapeutics for Inflammatory Bowel Diseases.
    Li Y; Chen J; Bolinger AA; Chen H; Liu Z; Cong Y; Brasier AR; Pinchuk IV; Tian B; Zhou J
    Inflamm Bowel Dis; 2021 Nov; 27(Suppl 2):S38-S62. PubMed ID: 34791293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Curcumin suppresses p38 mitogen-activated protein kinase activation, reduces IL-1beta and matrix metalloproteinase-3 and enhances IL-10 in the mucosa of children and adults with inflammatory bowel disease.
    Epstein J; Docena G; MacDonald TT; Sanderson IR
    Br J Nutr; 2010 Mar; 103(6):824-32. PubMed ID: 19878610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.